| Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses E Piotrowska, J Jakobkiewicz-Banecka, S Barańska, A Tylki-Szymańska, ... European Journal of Human Genetics 14 (7), 846-852, 2006 | 225 | 2006 |
| Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients E Piotrowska, J Jakóbkiewicz-Banecka, A Tylki-Szymanska, A Liberek, ... Current therapeutic research 69 (2), 166-179, 2008 | 138 | 2008 |
| Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal … J Jakóbkiewicz-Banecka, E Piotrowska, M Narajczyk, S Barańska, ... Journal of Biomedical Science 16, 1-9, 2009 | 137 | 2009 |
| Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice M Malinowska, FL Wilkinson, W Bennett, KJ Langford-Smith, HA O’Leary, ... Molecular genetics and metabolism 98 (3), 235-242, 2009 | 135 | 2009 |
| The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation M Moskot, S Montefusco, J Jakóbkiewicz-Banecka, P Mozolewski, ... Journal of Biological Chemistry 289 (24), 17054-17069, 2014 | 131 | 2014 |
| Models in the research process of psoriasis K Bocheńska, E Smolińska, M Moskot, J Jakóbkiewicz-Banecka, ... International journal of molecular sciences 18 (12), 2514, 2017 | 130 | 2017 |
| Molecular factors involved in the development of diabetic foot syndrome B Brun-Olszewska, A Korzon-Burakowska, M Gabig-Cimińska, ... Acta Biochimica Polonica 59, 507-513, 2012 | 97 | 2012 |
| MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC) D Dworakowska, E Jassem, J Jassem, B Peters, R Dziadziuszko, M Żylicz, ... Lung cancer 43 (3), 285-295, 2004 | 88 | 2004 |
| Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases J Jakóbkiewicz-Banecka, A Węgrzyn, G Węgrzyn Journal of applied genetics 48, 383-388, 2007 | 85 | 2007 |
| Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients E Piotrowska, J Jakobkiewicz-Banecka, A Maryniak, A Tylki-Szymanska, ... Medical Science Monitor: international medical journal of experimental and …, 2011 | 79 | 2011 |
| Genistein: a natural isoflavone with a potential for treatment of genetic diseases G Węgrzyn, J Jakobkiewicz-Banecka, M Gabig-Cimińska, E Piotrowska, ... Biochemical Society Transactions 38 (2), 695-701, 2010 | 73 | 2010 |
| Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses A Kloska, J Jakóbkiewicz-Banecka, M Narajczyk, Z Banecka-Majkutewicz, ... Metabolic brain disease 26, 1-8, 2011 | 66 | 2011 |
| Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different? G Węgrzyn, J Jakóbkiewicz-Banecka, M Narajczyk, A Wiśniewski, ... Medical Hypotheses 75 (6), 605-609, 2010 | 60 | 2010 |
| Glycosaminoglycans and mucopolysaccharidosis type III J Jakobkiewicz-Banecka, M Gabig-Cimińska, A Kloska, M Malinowska, ... Frontiers in Bioscience, 2016 | 58 | 2016 |
| Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease D Dziedzic, G Węgrzyn, J Jakóbkiewicz-Banecka European Journal of Human Genetics 18 (2), 200-205, 2010 | 57 | 2010 |
| Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression‐targeted isoflavone therapy (GET IT) J Marucha, A Tylki‐Szymańska, J Jakóbkiewicz‐Banecka, E Piotrowska, ... American Journal of Medical Genetics Part A 155 (9), 2257-2262, 2011 | 56 | 2011 |
| Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four … E Pronicka, A Węglewska-Jurkiewicz, J Taybert, M Pronicki, ... Journal of applied genetics 52, 61-66, 2011 | 56 | 2011 |
| Lipids and lipid mediators associated with the risk and pathology of ischemic stroke A Kloska, M Malinowska, M Gabig-Cimińska, J Jakóbkiewicz-Banecka International Journal of Molecular Sciences 21 (10), 3618, 2020 | 55 | 2020 |
| Female Fabry disease patients and X-chromosome inactivation P Juchniewicz, A Kloska, A Tylki-Szymańska, J Jakóbkiewicz-Banecka, ... Gene 641, 259-264, 2018 | 55 | 2018 |
| Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids M Moskot, J Jakóbkiewicz-Banecka, A Kloska, E Smolińska, ... Scientific Reports 5 (1), 9378, 2015 | 55 | 2015 |
